Study on the precise treatment of schizophrenia patients in the subgroup of blunted niacin response
Not Applicable
Completed
- Conditions
- SchizophreniaMental and Behavioural Disorders
- Registration Number
- ISRCTN10306750
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 138
Inclusion Criteria
1. Patients with schizophrenia diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria
2. Age between 18 and 65 years
3. Commitment to comply with the study procedures and cooperate with the implementation of the entire research process
Exclusion Criteria
1. Severe neurological diseases or traumatic brain injury
2. Substance dependence
3. Administration of nonsteroidal or steroidal anti-inflammatory drugs within 2 weeks
4. Having a history of severe allergies, currently suffering from skin diseases or immune system diseases
5. Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method